Filing Details

Accession Number:
0001213900-19-026561
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-19 16:01:31
Reporting Period:
2019-12-17
Accepted Time:
2019-12-19 16:01:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1791091 Healthcare Merger Corp. HCCOU () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245353 J Steven Shulman C/O Healthcare Merger Corp.
623 Fifth Avenue, 14Th Floor
New NY 10022
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-12-17 700,000 $10.00 700,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2019-12-17 75,000 $0.00 75,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,250,000 No 4 J Indirect
Footnotes
  1. These shares are underlying units (each unit consisting of one share of Class A common stock and one-half of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) held by HCMC Sponsor LLC (the "Sponsor"), acquired pursuant to a unit subscription agreement by and between the Sponsor and the issuer. Does not include 6,250,000 shares of Class B common stock, which shares will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis subject to certain adjustments.
  2. Steven Shulman is the Chief Executive Officer and a director of the issuer. He is also a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the securities held directly by the Sponsor. Mr. Shulman disclaims any beneficial ownership of the reported securities other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
  3. As described in the issuer's registration statement on Form S-1 (File No. 333-235253) under the heading "Description of Securities--Founder Shares and Placement Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments and has no expiration date.
  4. As contemplated in connection with the initial public offering of the issuer, 75,000 shares of Class B common stock of the issuer were returned by the Sponsor to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised in full.